featured
Liraglutide Reduces Hyperglycemia and Body Weight in Overweight, Dysregulated Insulin Pump–Treated Patients With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Liraglutide Reduces Hyperglycaemia and Body Weight in Overweight, Dysregulated Insulin-Pump-Treated Patients With Type 1 Diabetes: The Lira Pump Trial – A Randomized, Double-Blinded, Placebo-Controlled Trial
Diabetes Obes Metab 2019 Nov 06;[EPub Ahead of Print], TF Dejgaard, S Schmidt, CS Frandsen, D Vistisen, S Madsbad, HU Andersen, K NørgaardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.